Innovating Works

LEANBIO

Activa
Phoenix: Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative Products LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY tramitó un H2020: Nano-pharmaceuticals have the potential to drive the scientific and technological uplift, offering great clinical and socio-economic benefits to the society in general, industry and key stakeholders a...
2021-03-01 | Financiado
Smart-4-Fabry: Smart multifunctional GLA-nanoformulation for Fabry disease CENTRO DE INVESTIGACION BIOMEDICA EN RED CIBER tramitó un H2020: Lysosomal storage disorders (LSD) diseases are a group of rare diseases that currently lack a definitive cure. LSD incidence is about 1:5,000 - 1:10,000, representing a serious global health problem....
2017-01-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.